John L. Higgins
2011
In 2011, John L. Higgins earned a total compensation of $1.6M as President and Chief Executive Officer at Ligand Pharmaceuticals, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $317,888 |
|---|---|
| Option Awards | $738,128 |
| Salary | $423,850 |
| Stock Awards | $150,750 |
| Other | $2,540 |
| Total | $1,633,156 |
Higgins received $738.1K in option awards, accounting for 45% of the total pay in 2011.
Higgins also received $317.9K in non-equity incentive plan, $423.9K in salary, $150.8K in stock awards and $2.5K in other compensation.
Rankings
In 2011, John L. Higgins' compensation ranked 3,938th out of 10,747 executives tracked by ExecPay. In other words, Higgins earned more than 63.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,938 out of 10,747 | 63rd |
Division Manufacturing | 1,385 out of 3,960 | 65th |
Major group Chemicals And Allied Products | 280 out of 1,033 | 73rd |
Industry group Drugs | 160 out of 781 | 80th |
Industry Pharmaceutical Preparations | 130 out of 571 | 77th |
Source: SEC filing on April 21, 2014.
Higgins' colleagues
We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2011.